Free Trial
ASX:DNA

Donaco International (DNA) Stock Price, News & Analysis

Donaco International logo

About Donaco International Stock (ASX:DNA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
657,200 shs
Average Volume
N/A
Market Capitalization
A$35.79 million
P/E Ratio
0.90
Dividend Yield
2.86%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Donaco International and its competitors with MarketBeat's FREE daily newsletter.

DNA Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Donaco International Ltd. Reports Strong FY24 Growth
See More Headlines

DNA Stock Analysis - Frequently Asked Questions

Donaco International Limited (ASX:DNA) issued its quarterly earnings data on Thursday, February, 28th. The company reported ($0.05) earnings per share (EPS) for the quarter. Donaco International had a trailing twelve-month return on equity of 29.02% and a net margin of 81.03%.

Company Calendar

Last Earnings
2/28/2019
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Resorts & Casinos
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:DNA
CIK
N/A
Fax
N/A
Employees
640
Year Founded
N/A

Profitability

Trailing P/E Ratio
0.90
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$37.06 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$39.53 million
Price / Cash Flow
1.23
Book Value
A$0.12 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,230,000,000
Free Float
N/A
Market Cap
A$35.79 million
Optionable
Not Optionable
Beta
1.20
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:DNA) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners